(NVO) Novo Nordisk - Performance -51.7% in 12m
Compare NVO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
41.29%
#28 in Group
Rel. Strength
11.50%
#7069 in Universe
Total Return 12m
-51.74%
#143 in Group
Total Return 5y
96.61%
#18 in Group
P/E 19.7
51th Percentile in Group
P/E Forward 16.2
61th Percentile in Group
PEG 1.00
53th Percentile in Group
FCF Yield 3.89%
85th Percentile in Group
12m Total Return: NVO (-51.7%) vs XLV (-0.5%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
10.2% | 175% | 405% | 55.8 | 41 | 0.61 | 61.4% | 10.7% |
LLY NYSE Eli Lilly |
2.12% | 13.3% | 466% | 62.7 | 31.5 | 1.05 | 40.3% | 34.5% |
NVS NYSE Novartis |
-1.21% | 24.1% | 59.8% | 18 | 12.9 | 1.23 | 36.2% | 11% |
SFZN SW Siegfried Holding |
-2.09% | 1.78% | 95.3% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
SUPN NASDAQ Supernus Pharmaceuticals |
-4.71% | 6.55% | 74.3% | 24 | 20.2 | 1.47 | -20.8% | -17% |
SOBI ST Swedish Orphan Biovitrum |
-8.43% | 1.39% | 42.8% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
SAN PA Sanofi |
-15.7% | 10.9% | 24.2% | 21.9 | 11.6 | 0.93 | -22.1% | -24.8% |
NOVN SW Novartis |
-7.92% | 11.1% | 33.1% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
Performance Comparison: NVO vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for NVO
Total Return (including Dividends) | NVO | XLV | S&P 500 |
---|---|---|---|
1 Month | -27.12% | -7.37% | -5.89% |
3 Months | -27.17% | -4.55% | -12.45% |
12 Months | -51.74% | -0.54% | 6.72% |
5 Years | 96.61% | 46.59% | 101.06% |
Trend Score (consistency of price movement) | NVO | XLV | S&P 500 |
1 Month | -88.7% | -82.6% | -74.5% |
3 Months | -72.0% | -37.8% | -88.2% |
12 Months | -88.9% | -1.6% | 66.1% |
5 Years | 93.3% | 90.1% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #157 | -21.3% | -22.6% |
3 Month | #127 | -23.7% | -16.8% |
12 Month | #144 | -51.5% | -54.8% |
5 Years | #18 | 34.1% | -2.21% |
FAQs
Does NVO Novo Nordisk outperforms the market?
No,
over the last 12 months NVO made -51.74%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.54%.
Over the last 3 months NVO made -27.17%, while XLV made -4.55%.
Over the last 3 months NVO made -27.17%, while XLV made -4.55%.
Performance Comparison NVO vs Indeces and Sectors
NVO vs. Indices NVO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -8.86% | -21.2% | -40.6% | -58.5% |
US NASDAQ 100 | QQQ | -8.0% | -20.8% | -40.1% | -57.3% |
US Dow Jones Industrial 30 | DIA | -7.69% | -21.3% | -41.2% | -57.1% |
German DAX 40 | DAX | -14.2% | -17.7% | -57.7% | -70.0% |
Shanghai Shenzhen CSI 300 | CSI 300 | -9.57% | -19.6% | -42.9% | -57.6% |
Hongkong Hang Seng | HSI | -13.2% | -17.3% | -42.2% | -68.0% |
India NIFTY 50 | INDA | -13.2% | -31.9% | -43.1% | -54.8% |
Brasil Bovespa | EWZ | -12.4% | -22.0% | -43.6% | -42.3% |
NVO vs. Sectors NVO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -9.11% | -21.5% | -49.5% | -65.3% |
Consumer Discretionary | XLY | -7.99% | -23.2% | -43.4% | -61.0% |
Consumer Staples | XLP | -12.2% | -30.3% | -50.9% | -65.7% |
Energy | XLE | -13.6% | -17.0% | -41.7% | -41.5% |
Financial | XLF | -10.2% | -22.6% | -48.8% | -70.7% |
Health Care | XLV | -9.26% | -19.8% | -39.2% | -51.2% |
Industrial | XLI | -9.98% | -22.4% | -40.7% | -57.1% |
Materials | XLB | -10.6% | -20.5% | -33.6% | -44.2% |
Real Estate | XLRE | -14.2% | -24.2% | -42.0% | -68.9% |
Technology | XLK | -7.50% | -18.2% | -33.8% | -50.5% |
Utilities | XLU | -12.2% | -26.7% | -46.4% | -76.1% |
Aerospace & Defense | XAR | -10.6% | -27.2% | -50.4% | -75.9% |
Biotech | XBI | -12.4% | -15.2% | -26.1% | -42.8% |
Homebuilder | XHB | -9.81% | -20.3% | -22.7% | -42.6% |
Retail | XRT | -10.6% | -25.0% | -36.0% | -47.4% |